SEATTLE (AP) _ Adaptive Biotechnologies Corp. (ADPT) on Tuesday reported a loss of $36.7 million in its third quarter.

On a per-share basis, the Seattle-based company said it had a loss of 27 cents.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 28 cents per share.

The life-sciences research company posted revenue of $26.3 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $23.4 million.

Adaptive Biotechnologies shares have climbed 57% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $47.02, a rise of 66% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADPT at https://www.zacks.com/ap/ADPT

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News